The ILK/LIMD2 complex and the regulation of ILK activity by LIMD2 suggest a potential mechanism for upregulation of ILK activity specifically in metastatic cancer cells [18]. The gene discussed is LIMD2; the disease is metastatic malignant neoplasm.